Hospira nabs Indian API plant for $200M

Hospira ($HSP) has snapped up an API plant and R&D facility from India's Orchid Pharmaceuticals. The $200 million deal will secure supplies of active ingredients for certain antibiotics and will help it cut costs as well. Report